NTCP Inhibitors
DBCAT005809Pharmacologic class
Group of drugs that inhibit the sodium-taurocholate co-transporting polypeptide (NTCP). A DrugBank category of 7 drugs. 6 of them are approved.
What you can answer from here — as of March 13, 2023
7DrugsEach linked to its full drug cardListed above
Which targets do NTCP Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account